These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24719252)

  • 1. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.
    Tu H; Ahearn TU; Daniel CR; Gonzalez-Feliciano AG; Seabrook ME; Bostick RM
    Mol Carcinog; 2015 Sep; 54(9):821-30. PubMed ID: 24719252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
    Kwan AK; Um CY; Rutherford RE; Seabrook ME; Barry EL; Fedirko V; Baron JA; Bostick RM
    Mol Carcinog; 2019 Apr; 58(4):511-523. PubMed ID: 30499618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial.
    Tu H; Flanders WD; Ahearn TU; Daniel CR; Gonzalez-Feliciano AG; Long Q; Rutherford RE; Bostick RM
    Mol Carcinog; 2015 Apr; 54(4):270-80. PubMed ID: 24166893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.
    Ahearn TU; Shaukat A; Flanders WD; Seabrook ME; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):969-79. PubMed ID: 22539608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.
    Yang B; Thyagarajan B; Gross MD; Goodman M; Sun YV; Bostick RM
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E187-92. PubMed ID: 23776012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.
    Daniel CR; Bostick RM; Flanders WD; Long Q; Fedirko V; Sidelnikov E; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):65-73. PubMed ID: 19124482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.
    Liu S; Barry EL; Baron JA; Rutherford RE; Seabrook ME; Bostick RM
    Mol Carcinog; 2017 Feb; 56(2):412-424. PubMed ID: 27254743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue localization of TGFalpha and apoptosis are inversely related in colorectal tumors.
    Habel O; Bertario L; Andreola S; Sirizzotti G; Marian B
    Histochem Cell Biol; 2002 Mar; 117(3):235-41. PubMed ID: 11914921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.
    Pannain VL; Morais JR; Damasceno-Ribeiro O; Avancini-Alves V
    Ann Hepatol; 2012; 11(4):495-9. PubMed ID: 22700631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose.
    Hardman WE; Cameron IL; Beer WH; Speeg KV; Kadakia SC; Lang KA
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):633-7. PubMed ID: 9264277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of precursor transforming growth factor beta1 in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjo A
    Int J Mol Med; 2001 Jun; 7(6):597-601. PubMed ID: 11351271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
    Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
    J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.
    Berndt SI; Huang WY; Chatterjee N; Yeager M; Welch R; Chanock SJ; Weissfeld JL; Schoen RE; Hayes RB
    Carcinogenesis; 2007 Sep; 28(9):1965-70. PubMed ID: 17615257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
    Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.